G269-0399 Screening compound: 5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

G269-0399 Screening compound: 5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide
G269-0399 Screening compound: 5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G269-0399
5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G269-0399

Molecular Formula

C24H32N4O3S2 (C24 H32 N4 O3 S2)

Compound Name

5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide

IUPAC name

5-acetyl-N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-2345-tetrahydro-15-benzothiazepine-7-sulfonamide

SMILES

CCN1CCN(Cc(cc2)ccc2NS(c(cc2)cc3c2SCCCN3C(C)=O)(=O)=O)CC1

InChI

InChI=1S/C24H32N4O3S2/c1-3-26-12-14-27(15-13-26)18-20-5-7-21(8-6-20)25-33(30,31)22-9-10-24-23(17-22)28(19(2)29)11-4-16-32-24/h5-10,17,25H,3-4,11-16,18H2,1-2H3

InChI Key

RMNGZQCYGSZZQP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27212307

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.68

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.822

Distribution Coefficient, logD

1.891

Water Solubility, LogSw

-3.47

Polar Surface Area

64.541

Acid Dissociation Constant (pKa)

8.06

Base Dissociation Constant (pKb)

8.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.80

G269-0399 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G269-0399 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G269-0399?
Check Price and Availability of G269-0399, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G269-0399 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G269-0399
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G269-0399
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G269-0399 available by request